Navigating large-volume subcutaneous injections of biopharmaceuticals: a systematic review of clinical pipelines and approved products
Subcutaneous (SC) administration is transforming the delivery of biopharmaceuticals, facilitating care in a variety of healthcare settings, including home self-treatment. Large-volume single SC doses have gained attention for their potential to expand therapeutic applications and improve long-term,...
Saved in:
Main Authors: | Philip Green, Andreas Schneider, Jakob Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2402713 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What are biopharmaceuticals?
by: Abhay H. Pande, et al.
Published: (2025-01-01) -
Predicting the clinical subcutaneous absorption rate constant of monoclonal antibodies using only the primary sequence: a machine learning approach
by: Ronghua Bei, et al.
Published: (2024-12-01) -
Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
by: Caitlin Fawcett, et al.
Published: (2024-12-01) -
Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability
by: Lebar Blaž, et al.
Published: (2024-09-01) -
Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities
by: Nai Lee, et al.
Published: (2025-01-01)